The TCR interaction with pMHC is both sensitive and specific. Cognate pMHC class II complexes are able to activate CD4 T cells when as few as 0·03% of total MHC molecules present on the cell surface contain antigen [14]. T cells flux calcium ions in response to engagement of a single MHC [15] and CD8 T cell clones can be activated by as few as 1–50 pMHCI complexes [16,17]. Single amino acid substitution of presented peptides dictates strongly the ability of T cells to respond to the antigen [18]. Such sensitivity and specificity allows for appropriate responses to low levels of presentation of non-self antigen. However,

as it is known that pMHCI/TCR interactions are very weak, this has led to much interest in how this Doxorubicin nmr sensitivity and specificity are achieved. Kinetic models of the TCR : pMHCI interaction are popular approaches to explain this paradox. The serial engagement model proposes that a single agonist pMHCI engages multiple TCRs on a given T cell to enable sustained engagement and CTL triggering [17,19]. This is thought to explain the observation that T cell activation is possible despite low physiological levels of pMHCI on the surface of cells

[16,17]. The low affinity of the TCR : pMHCI interaction enables rapid dissociation, ensuring that serial TCRs are able to engage [20]. The kinetic proof-reading model suggests that the TCR : pMHCI complex must engage for a minimum half-life (t ) for completion of intracellular signalling events: if Veliparib cell line the off rate is too rapid the T cell cannot be activated [21–23]. The kinetic discrimination model expands on this to suggest that incomplete receptor activation leads to inhibition of T cell activation [23]. Combined, these models predict that there is an optimal t1/2 required for T cell activation [20,24]. Too short a t1/2 fails to activate T cells and too long a t1/2 results in too long an interaction preventing serial engagement [17,25].

Bacterial neuraminidase These models have been supported by experimental data using TCR mutants conferring varying half-lives on the TCR : pMHCI interaction [25–29]. Thus, although the details of TCR activation still require much further work, a central role for TCR off-rate and TCR affinity in determining the threshold for triggering of a CD8+ T cell in response to peptide appears to be emerging. Many groups have hypothesized that this triggering threshold may impact to the function or ‘quality’ of T cells in vivo. In fact, surface plasmon resonance (SPR) has been used to show that the affinity of the interaction between TCR and pMHCI correlates with the ‘quality’ of the response of T cell clones [30].